Conmed (CNMD) Other financing activities (2011 - 2026)

Conmed has reported Other financing activities for 16 years, with the latest figure at $828000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities rose 278.45% year-over-year to $828000.0; the trailing twelve-month figure through Mar 2026 stood at $4.2 million (up 81.97% YoY), and the FY2025 full-year result was $2.9 million, up 2.26% from the prior year.
• Other financing activities for Q1 2026 stood at $828000.0, down from $2.9 million in the prior quarter.
• The five-year high for Other financing activities was $15.4 million in Q3 2022, with the low at -$13.4 million in Q4 2022.
• Historically, Other financing activities has averaged $2.1 million across 5 years, with a median of $916000.0 in 2023.
• Annual changes were most pronounced in 2023 — Other financing activities surged 3494.6% — and 2025, when it plunged 792.54%.
• Conmed's Other financing activities stood at -$13.4 million in 2022, then soared by 109.36% to $1.2 million in 2023, then jumped by 126.64% to $2.8 million in 2024, then rose by 1.59% to $2.9 million in 2025, then plunged by 71.23% to $828000.0 in 2026.
• The last three Other financing activities figures came in at $828000.0 (Q1 2026), $2.9 million (Q3 2025), and $483000.0 (Q2 2025), per Business Quant data.